MRKR Marker Therapeutics, Inc.
$0.89▼ -1.74%
Healthcare
Other
Volume 12.8K
Avg Volume (10D) 286.9K
Key Metrics & Fundamentals
Market Cap
$14.85M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.84 - 2.46
% vs 50 MA
-22.03%
% vs 200 MA
-34.58%
RSI-14
38.7
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.98
Free Cash Flow
-$3.72M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$1.94M
COGS
–
Operating Exp
$1.94M
Operating Income
-$1.94M
EBIT
-$1.94M
Pretax Income
-$1.83M
Net Income
-$1.83M
EPS (Diluted)
-0.09
Price & Volume History
Loading chart…
Recent News
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
GlobeNewswire · Oct 19, 2026 7:00 AM ET
All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
Zacks · Oct 16, 2026 11:00 AM ET
New Strong Buy Stocks for October 16th
Zacks · Oct 16, 2026 3:04 AM ET
Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
GlobeNewswire · Sep 22, 2026 8:00 AM ET
Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
Zacks · Aug 6, 2026 9:50 AM ET
Financial Overview - Income Statement
Quarterly
Dec 2024
See MRKR's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.